e-learning
resources
Paris 2018
Monday, 17.09.2018
Granulomatous disorders: heterogeneous diseases with variable management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sarcoidosis: imagiological findings and their impact on the disease outcome
R. Estêvão Gomes (Lisboa, Portugal), M. Barata (Lisboa, Portugal), C. Monge (Lisboa, Portugal), M. Lopes (Lisboa, Portugal), J. Soares (Lisboa, Portugal), J. Duarte (Lisboa, Portugal)
Source:
International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Session:
Granulomatous disorders: heterogeneous diseases with variable management
Session type:
Thematic Poster
Number:
3014
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Estêvão Gomes (Lisboa, Portugal), M. Barata (Lisboa, Portugal), C. Monge (Lisboa, Portugal), M. Lopes (Lisboa, Portugal), J. Soares (Lisboa, Portugal), J. Duarte (Lisboa, Portugal). Sarcoidosis: imagiological findings and their impact on the disease outcome. 3014
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Thoracic manifestations of systemic autoimmune diseases: radiological findings
Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology
Year: 2007
Clinical manifestations of neurological involvement in sarcoidosis
- in our experience
Source: Eur Respir J 2004; 24: Suppl. 48, 711s
Year: 2004
Sarcoidosis with extra-thoracic lesions: clinical aspects
Source: Eur Respir J 2002; 20: Suppl. 38, 435s
Year: 2002
Sarcoidosis: pathological features and differential diagnosis
Source: Eur Respir Monogr 2022; 96: 91-106
Year: 2022
Pulmonary veno-occlusive disease: clinical, functional, radiologic and hemodynamic characteristics and outcome of 24 cases confirmed by histology
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Severe sarcoidosis: clinical features and management
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021
Sarcoidosis: pulmonary manifestations and management
Source: Eur Respir Monogr 2019; 86: 404-418
Year: 2019
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Sarcoidosis: Clinical course and prognostic predictors
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010
Clinical course of childhood asthma: a role of disease severity
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
Unclassifiable interstitial lung disease: predictive factors of mortality and radiologic features
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Prognostic impact of radiological findings in unclassifiable interstitial lung diseases
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Sarcoidosis – an initial radiological and clinical presentation in various ethnic groups
Source: Eur Respir J 2007; 30: Suppl. 51, 115s
Year: 2007
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Pleuropulmonary ultrasound findings and their association with chronic liver disease severity
Source: International Congress 2019 – Use of thoracic ultrasound to diagnose lung diseases
Year: 2019
Sarcoidosis treatment and outcomes: what is most important to patients?
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
The evaluation of disease severity/staging for prognosis
Source: Eur Respir Monogr 2016; 71: 97-105
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept